MATOD Module 3 - Long-acting Injectable Buprenorphine
Medication Assisted Treatment for Opioid Dependence
Module 3 - Long-acting injectable buprenorphine: Builds on knowledge of prescribing and administering long-acting injection buprenorphine, including how to select, initiate and manage patients who are using these new opioid substitutions.
On completion of modules 1 and 2 you'll be trained and recognised as a prescriber for methadone and buprenorphine based assisted treatment of opioid dependence.
Please contact MATOD Program Coordinator, Kerrianne Singleton on 03 8699 0468 or via email at vic.MATOD@racgp.org.au if you don't have a RACGP number.
- Correctly interpret legislative frameworks and evidence-based clinical guidelines for the use of Long-Acting Injection Buprenorphine
- Describe the options available for opioid dependent people who are considering Long-Acting Injection Buprenorphine
- Apply pharmaceutical knowledge and rationale to the prescribing principles for Long-Acting Injection Buprenorphine
This event attracts 4 CPD points